Through our tried-and-tested model for stimulating essential healthcare companies to do more to reach people in low- and middle-income countries, the Access to Medicine Foundation has had a demonstrable impact on expanding access to medicine.
An interview with Dr Zainab Shinkafi Bagudu, CEO at Medicaid Cancer Foundation
The interview highlights how governments and civil society are using the Foundation’s insights to engage with the private sector to achieve results.
When I talk to executives from pharmaceutical companies they tell me that they want to do more for neglected diseases, but they at least need to get credit for it. The Access to Medicine Index does exactly that.
Bill Gates
Co-chair and Trustee, Bill & Melinda Gates Foundation
An interview with Michael Oberreiter, Roche, and Pritha Paul, Biocon Biologics Limited
The interview highlights how the Foundation's work has positively impacted the companies, from showcasing best practices to providing insights that can be used to expand access.
Africa has been overlooked when it comes to research and development of life-saving medical commodities, including COVID-19 vaccines. Free market demand and supply principles will not work on their own without an equitable access dimension. The Access to Medicine Foundation is important for accountability - tracking how and where healthcare companies live up to their commitments; as well as encouraging them to do better – in bridging gaps in equitable access to health products and achieving universal health coverage.
An interview with Frank Wagemans, Senior Engagement Specialist at Achmea IM
He shines a light on how his investment management firm is using the Foundation's insights to drive change and move healthcare companies towards expanding access to medicine in low- and middle-income countries.
.png)
